Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker NWFL
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | Vincent O'Bell EVP & Chief Lending Officer | NWFL Norwood Financial Corp. | Sale | 300 | $34.68 | $10.4K Sale | Form 4 ↗ |
| Sep 2, 2026 | Vincent O'Bell EVP & Chief Lending Officer | NWFL Norwood Financial Corp. | Sale | 100 | $34.61 | $3,461 Sale | Form 4 ↗ |
| Sep 2, 2026 | Vincent O'Bell EVP & Chief Lending Officer | NWFL Norwood Financial Corp. | Sale | 1,100 | $34.50 | $38.0K Sale | Form 4 ↗ |
| Sep 2, 2026 | Vincent O'Bell EVP & Chief Lending Officer | NWFL Norwood Financial Corp. | Sale | 1,500 | $34.50 | $51.8K Sale | Form 4 ↗ |
| Jul 28, 2026 | James Shook Director | NWFL Norwood Financial Corp. | Buy | 3,100 | $34.55 | $107.1K Buy | Form 4 ↗ |
| May 26, 2026 | Ronald R. Schmalzle Director | NWFL Norwood Financial Corp. | Buy | 700 | $30.19 | $21.1K Buy | Form 4 ↗ |
| May 12, 2026 | Andrew Forte Director | NWFL Norwood Financial Corp. | Buy | 270 | $29.58 | $7,987 Buy | Form 4 ↗ |
| May 5, 2026 | Joseph W. Carroll Director | NWFL Norwood Financial Corp. | Buy | 276 | $29.46 | $8,131 Buy | Form 4 ↗ |
| May 5, 2026 | Joseph W. Carroll Director | NWFL Norwood Financial Corp. | Buy | 100 | $29.42 | $2,942 Buy | Form 4 ↗ |
| May 5, 2026 | Joseph W. Carroll Director | NWFL Norwood Financial Corp. | Buy | 96 | $29.46 | $2,828 Buy | Form 4 ↗ |
| May 5, 2026 | Joseph W. Carroll Director | NWFL Norwood Financial Corp. | Buy | 100 | $29.44 | $2,944 Buy | Form 4 ↗ |
| May 5, 2026 | Joseph W. Carroll Director | NWFL Norwood Financial Corp. | Buy | 24 | $29.43 | $706 Buy | Form 4 ↗ |
| May 5, 2026 | Joseph W. Carroll Director | NWFL Norwood Financial Corp. | Buy | 76 | $29.46 | $2,239 Buy | Form 4 ↗ |
| May 1, 2026 | Joseph W. Carroll Director | NWFL Norwood Financial Corp. | Buy | 180 | $29.61 | $5,330 Buy | Form 4 ↗ |
| Apr 30, 2026 | James Shook Director | NWFL Norwood Financial Corp. | Buy | 375 | $29.06 | $10.9K Buy | Form 4 ↗ |
| Apr 30, 2026 | John Martin McCaffery Jr. EVP & CFO | NWFL Norwood Financial Corp. | Buy | 1,000 | $29.44 | $29.4K Buy | Form 4 ↗ |
| Apr 29, 2026 | James O. Donnelly President & CEO, Director | NWFL Norwood Financial Corp. | Buy | 100 | $29.06 | $2,906 Buy | Form 4 ↗ |
| Jan 28, 2026 | Joseph W. Carroll Director | NWFL Norwood Financial Corp. | Buy | 2,000 | $28.21 | $56.4K Buy | Form 4 ↗ |
| Jan 28, 2026 | Joseph W. Carroll Director | NWFL Norwood Financial Corp. | Buy | 1,996 | $28.06 | $56.0K Buy | Form 4 ↗ |
| Jan 28, 2026 | Joseph W. Carroll Director | NWFL Norwood Financial Corp. | Buy | 4 | $28.05 | $112 Buy | Form 4 ↗ |
| Jan 28, 2026 | James Shook Director | NWFL Norwood Financial Corp. | Buy | 3,500 | $28.80 | $100.8K Buy | Form 4 ↗ |
| Jan 27, 2026 | Joseph W. Carroll Director | NWFL Norwood Financial Corp. | Buy | 2,000 | $27.91 | $55.8K Buy | Form 4 ↗ |
| Jan 27, 2026 | James O. Donnelly President & CEO, Director | NWFL Norwood Financial Corp. | Buy | 200 | $28.15 | $5,630 Buy | Form 4 ↗ |
| Oct 31, 2025 | Kenneth A. Phillips Director | NWFL Norwood Financial Corp. | Buy | 50 | $26.30 | $1,315 Buy | Form 4 ↗ |
| Oct 31, 2025 | Kenneth A. Phillips Director | NWFL Norwood Financial Corp. | Buy | 100 | $26.50 | $2,650 Buy | Form 4 ↗ |
| Oct 27, 2025 | James Shook Director | NWFL Norwood Financial Corp. | Buy | 100 | $26.58 | $2,658 Buy | Form 4 ↗ |
| Oct 27, 2025 | James Shook Director | NWFL Norwood Financial Corp. | Buy | 1,937 | $26.63 | $51.6K Buy | Form 4 ↗ |
| Oct 27, 2025 | James Shook Director | NWFL Norwood Financial Corp. | Buy | 200 | $26.62 | $5,324 Buy | Form 4 ↗ |
| Oct 27, 2025 | James Shook Director | NWFL Norwood Financial Corp. | Buy | 1,563 | $26.82 | $41.9K Buy | Form 4 ↗ |
| Aug 6, 2025 | James O. Donnelly President & CEO, Director | NWFL Norwood Financial Corp. | Buy | 200 | $23.90 | $4,780 Buy | Form 4 ↗ |
| Aug 5, 2025 | Ronald R. Schmalzle Director | NWFL Norwood Financial Corp. | Buy | 600 | $24.35 | $14.6K Buy | Form 4/A ↗ |
| Aug 1, 2025 | John Martin McCaffery Jr. EVP & CFO | NWFL Norwood Financial Corp. | Buy | 500 | $24.10 | $12.1K Buy | Form 4 ↗ |
| Jul 29, 2025 | Andrew Forte Director | NWFL Norwood Financial Corp. | Buy | 400 | $24.57 | $9,828 Buy | Form 4 ↗ |
| Jul 25, 2025 | James O. Donnelly President & CEO, Director | NWFL Norwood Financial Corp. | Buy | 100 | $24.40 | $2,440 Buy | Form 4 ↗ |
| Apr 30, 2025 | John Martin McCaffery Jr. EVP & CFO | NWFL Norwood Financial Corp. | Buy | 500 | $25.00 | $12.5K Buy | Form 4 ↗ |
| Apr 25, 2025 | Andrew Forte Director | NWFL Norwood Financial Corp. | Buy | 485 | $24.50 | $11.9K Buy | Form 4 ↗ |
| Apr 24, 2025 | James O. Donnelly President & CEO, Director | NWFL Norwood Financial Corp. | Buy | 100 | $24.30 | $2,430 Buy | Form 4 ↗ |
| Feb 7, 2025 | Ronald R. Schmalzle Director | NWFL Norwood Financial Corp. | Buy | 2,800 | $26.49 | $74.2K Buy | Form 4 ↗ |
| Feb 5, 2025 | Ronald R. Schmalzle Director | NWFL Norwood Financial Corp. | Buy | 8,500 | $26.59 | $226.0K Buy | Form 4 ↗ |
| Feb 4, 2025 | Ronald R. Schmalzle Director | NWFL Norwood Financial Corp. | Buy | 6 | $26.26 | $158 Buy | Form 4 ↗ |
| Feb 4, 2025 | Ronald R. Schmalzle Director | NWFL Norwood Financial Corp. | Buy | 839 | $26.30 | $22.1K Buy | Form 4 ↗ |
| Feb 4, 2025 | Ronald R. Schmalzle Director | NWFL Norwood Financial Corp. | Buy | 1,712 | $26.50 | $45.4K Buy | Form 4 ↗ |
| Feb 4, 2025 | Ronald R. Schmalzle Director | NWFL Norwood Financial Corp. | Buy | 6 | $26.00 | $156 Buy | Form 4 ↗ |
| Jan 31, 2025 | Ronald R. Schmalzle Director | NWFL Norwood Financial Corp. | Buy | 3,129 | $26.00 | $81.4K Buy | Form 4/A ↗ |
| Jan 30, 2025 | Ronald R. Schmalzle Director | NWFL Norwood Financial Corp. | Buy | 2,000 | $26.00 | $52.0K Buy | Form 4 ↗ |
| Dec 20, 2024 | Vincent O'Bell EVP & Chief Lending Officer | NWFL Norwood Financial Corp. | Buy | 1,154 | $26.00 | $30.0K Buy | Form 4/A ↗ |
| Dec 19, 2024 | James O. Donnelly President & CEO, Director | NWFL Norwood Financial Corp. | Buy | 1,538 | $26.00 | $40.0K Buy | Form 4/A ↗ |
| Dec 19, 2024 | Ronald R. Schmalzle Director | NWFL Norwood Financial Corp. | Buy | 7,692 | $26.00 | $200.0K Buy | Form 4 ↗ |
48 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 6:40 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances